Beren Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
103
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$300M
- Investors
-
18
Beren Therapeutics General Information
Description
Developer of cyclodextrin-based therapeutics designed to discover, develop, and deliver novel therapies for conditions characterized by defective cholesterol trafficking while integrating the needs of patients, caregivers, clinicians, and health systems throughout the development process. The company offers cholesterol-trafficking focused therapeutics, expanded access support programs, and patient access initiatives, enabling patients with rare cholesterol trafficking disorders and their caregivers to access treatments and receive long-term clinical and family support.
Contact Information
Website
www.berentx.comCorporate Office
- 2101 Corporate Center Drive
- Newbury Park, Suite 100
- Thousand Oaks, CA 91320
- United States
Corporate Office
- 2101 Corporate Center Drive
- Newbury Park, Suite 100
- Thousand Oaks, CA 91320
- United States
Beren Therapeutics Timeline
Beren Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 10-Jun-2026 | $300M | Completed | Clinical Trials - Phase 3 | ||
| 3. Seed Round | 07-Feb-2023 | Completed | Clinical Trials - Phase 3 | |||
| 2. Seed Round | 01-Aug-2021 | $30M | Completed | Clinical Trials - Phase 3 | ||
| 1. Seed Round | 10-Aug-2020 | $30M | $30M | Completed | Clinical Trials - Phase 3 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Beren Therapeutics Comparisons
Industry
Financing
Details
Beren Therapeutics Competitors (5)
One of Beren Therapeutics’s 5 competitors is IntraBio, a Formerly VC-backed company based in Austin, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| IntraBio | Formerly VC-backed | Austin, TX | ||||
| Disc Medicine | Formerly VC-backed | Watertown, MA | ||||
| Rhythm Pharmaceuticals | Formerly VC-backed | Boston, MA | ||||
| Argenx | Formerly VC-backed | Zwijnaarde, Belgium | ||||
| Apellis Pharmaceuticals | Formerly VC-backed | Waltham, MA |
Beren Therapeutics Patents
Beren Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026172287-A1 | Cyclodextrin derivatives and uses thereof | Pending | 14-Feb-2025 | ||
| WO-2026172290-A1 | Cyclodextrin derivatives and uses thereof | Pending | 14-Feb-2025 | ||
| WO-2026022777-A1 | 2-hydroxypropyl beta-cyclodextrins for use in a method of treating niemann-pick disease type c in subjects with infantile onset | Pending | 26-Jul-2024 | ||
| WO-2026018209-A1 | Modified cyclodextrin compounds and methods for their use | Pending | 19-Jul-2024 | ||
| AU-2024323697-A1 | Isomerically pure beta-cyclodextrin derivatives and uses thereof | Pending | 16-Aug-2023 | C08B37/0012 |
Beren Therapeutics Signals
Beren Therapeutics Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Advection Growth Capital | Merchant Banking Firm | Minority | ||
| Athos Capital (Hong Kong) | Hedge Fund | Minority | ||
| Eisai | Corporate Venture Capital | Minority | ||
| Founders Fund | Venture Capital | Minority | ||
| Gaingels | Venture Capital | Minority |
Beren Therapeutics FAQs
-
When was Beren Therapeutics founded?
Beren Therapeutics was founded in 2020.
-
Where is Beren Therapeutics headquartered?
Beren Therapeutics is headquartered in Thousand Oaks, CA.
-
What is the size of Beren Therapeutics?
Beren Therapeutics has 103 total employees.
-
What industry is Beren Therapeutics in?
Beren Therapeutics’s primary industry is Drug Discovery.
-
Is Beren Therapeutics a private or public company?
Beren Therapeutics is a Private company.
-
What is Beren Therapeutics’s current revenue?
The current revenue for Beren Therapeutics is .
-
How much funding has Beren Therapeutics raised over time?
Beren Therapeutics has raised $330M.
-
Who are Beren Therapeutics’s investors?
Advection Growth Capital, Athos Capital (Hong Kong), Eisai, Founders Fund, and Gaingels are 5 of 18 investors who have invested in Beren Therapeutics.
-
Who are Beren Therapeutics’s competitors?
IntraBio, Disc Medicine, Rhythm Pharmaceuticals, Argenx, and Apellis Pharmaceuticals are competitors of Beren Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process